AGIOS PHARMACEUTICALS, INC. — Director's Dealing 2018

Nov 19, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AGIOS PHARMACEUTICALS INC (AGIO)
CIK: 0001439222
Period of Report: 2018-11-08

Reporting Person: Schenkein David P (Director, Chief Executive Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-11-08	Common stock	G	1000	$0.00	Disposed	270772	Indirect

Holdings (Non-Derivative)

Security	Shares	Ownership
Common stock	83849	Direct
Common stock	79082	Indirect

Footnotes

F1: This disposition reflects a gift of 1,000 shares to a charitable trust.

F2: Shares held by David P. Schenkein 2004 Revocable Trust, of which the reporting person is trustee and beneficiary.

F3: Shares held by Amy P. Schenkein 2004 Revocable Trust, of which the reporting person's spouse is trustee and beneficiary.